Annette Haberl

1.3k total citations
56 papers, 868 citations indexed

About

Annette Haberl is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Annette Haberl has authored 56 papers receiving a total of 868 indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Infectious Diseases, 23 papers in Virology and 21 papers in Epidemiology. Recurrent topics in Annette Haberl's work include HIV/AIDS Research and Interventions (26 papers), HIV/AIDS drug development and treatment (26 papers) and HIV Research and Treatment (23 papers). Annette Haberl is often cited by papers focused on HIV/AIDS Research and Interventions (26 papers), HIV/AIDS drug development and treatment (26 papers) and HIV Research and Treatment (23 papers). Annette Haberl collaborates with scholars based in Germany, United Kingdom and Italy. Annette Haberl's co-authors include Schlomo Staszewski, Christoph Stephan, Nils von Hentig, Peter Gute, Pavel Khaykin, Markus Bickel, Ingeborg Fraunholz, Claus Rödel, Eva Herrmann and Amina Carlebach and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Annette Haberl

51 papers receiving 843 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Annette Haberl Germany 18 499 310 285 154 125 56 868
George Perez United States 15 413 0.8× 353 1.1× 169 0.6× 143 0.9× 108 0.9× 36 785
Nikolas Wada United States 13 535 1.1× 313 1.0× 369 1.3× 419 2.7× 80 0.6× 17 980
José Ignacio Bernardino Spain 18 501 1.0× 408 1.3× 357 1.3× 403 2.6× 111 0.9× 95 992
Peter Gute Germany 18 868 1.7× 308 1.0× 688 2.4× 216 1.4× 45 0.4× 35 1.2k
Manuela Colafigli Italy 21 721 1.4× 287 0.9× 685 2.4× 347 2.3× 99 0.8× 63 1.1k
Herman G. Sprenger Netherlands 13 624 1.3× 223 0.7× 391 1.4× 396 2.6× 41 0.3× 41 994
Teresa Bini Italy 17 622 1.2× 278 0.9× 442 1.6× 313 2.0× 33 0.3× 65 962
Ruth Goodall United Kingdom 16 597 1.2× 242 0.8× 370 1.3× 118 0.8× 80 0.6× 47 893
Duncan Churchill United Kingdom 17 720 1.4× 241 0.8× 543 1.9× 284 1.8× 68 0.5× 50 1.1k
Wisit Prasithsirikul Thailand 23 730 1.5× 295 1.0× 331 1.2× 238 1.5× 33 0.3× 54 997

Countries citing papers authored by Annette Haberl

Since Specialization
Citations

This map shows the geographic impact of Annette Haberl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annette Haberl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annette Haberl more than expected).

Fields of papers citing papers by Annette Haberl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annette Haberl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annette Haberl. The network helps show where Annette Haberl may publish in the future.

Co-authorship network of co-authors of Annette Haberl

This figure shows the co-authorship network connecting the top 25 collaborators of Annette Haberl. A scholar is included among the top collaborators of Annette Haberl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annette Haberl. Annette Haberl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Haberl, Annette & Pavel Khaykin. (2024). Was bei der HIV-Therapie von Menschen aus der Ukraine zu beachten ist. MMW - Fortschritte der Medizin. 166(S2). 18–19.
2.
Schuettfort, Gundolf, Annemarie Berger, Emmanouil Fokas, et al.. (2023). Differences in the Course of CD4 and CD8 Cells After Chemoradiotherapy in People Living with HIV with Anal Cancer. AIDS Research and Human Retroviruses. 40(4). 198–203.
3.
Wetzstein, Nils, Gerrit Kann, Gundolf Schüttfort, et al.. (2021). Disseminated disease due to non-tuberculous mycobacteria in HIV positive patients: A retrospective case control study. PLoS ONE. 16(7). e0254607–e0254607. 9 indexed citations
4.
Audebert, Franz, Cornelia Feiterna‐Sperling, Daniel Gillor, et al.. (2021). Not Recommended, But Done: Breastfeeding with HIV in Germany. AIDS Patient Care and STDs. 35(2). 33–38. 22 indexed citations
5.
Kann, Gerrit, Annette Haberl, Timo Wolf, et al.. (2021). Evaluation of Platelet Activation by HIV Protease Inhibitors – The HIV-PLA II Study. HIV/AIDS - Research and Palliative Care. Volume 13. 789–800. 1 indexed citations
6.
Neukam, Karin, Daniela Munteanu, Antonio Rivero‐Juárez, et al.. (2015). Boceprevir or Telaprevir Based Triple Therapy against Chronic Hepatitis C in HIV Coinfection: Real-Life Safety and Efficacy. PLoS ONE. 10(4). e0125080–e0125080. 9 indexed citations
7.
Khaykin, Pavel, et al.. (2015). Efficacy of raltegravir-containing regimens in antiretroviral-naïve and -experienced individuals in routine clinical practice. International Journal of STD & AIDS. 27(13). 1170–1179. 7 indexed citations
8.
Schuettfort, Gundolf, Elke Hattingen, Ulrich Pilatus, et al.. (2014). Proton 1H‐ and Phosphorus 31P‐MR spectroscopy (MRS) in asymptomatic HIV‐positive patients. Journal of the International AIDS Society. 17(4S3). 19577–19577. 2 indexed citations
9.
Bickel, Markus, Nils von Hentig, Imke Wieters, et al.. (2010). Immune Response after Two Doses of the Novel Split Virion, Adjuvanted Pandemic H1N1 Influenza A Vaccine in HIV-1-Infected Patients. Clinical Infectious Diseases. 52(1). 122–127. 53 indexed citations
10.
Buchholz, B., Ulrich Marcus, Thomas Grubert, et al.. (2009). German-austrian recommendations for HIV1-therapy in pregnancy and in HIV1-exposed newborn - update 2008. European journal of medical research. 14(11). 359–76. 15 indexed citations
11.
Fraunholz, Ingeborg, et al.. (2009). Concurrent Chemoradiotherapy With 5-Fluorouracil and Mitomycin C for Invasive Anal Carcinoma in Human Immunodeficiency Virus-Positive Patients Receiving Highly Active Antiretroviral Therapy. International Journal of Radiation Oncology*Biology*Physics. 76(5). 1425–1432. 36 indexed citations
12.
Haberl, Annette, Christoph Stephan, Markus Bickel, et al.. (2009). Atazanavir plasma concentrations are impaired in HIV-1-infected adults simultaneously taking a methadone oral solution in a once-daily observed therapy setting. European Journal of Clinical Pharmacology. 66(4). 375–381. 6 indexed citations
13.
Hentig, Nils von, Pavel Khaykin, Christoph Stephan, et al.. (2008). Pharmacokinetics, Safety and Efficacy of Saquinavir/ Ritonavir 1,000/100 Mg Twice Daily as HIV Type-1 Therapy and Transmission Prophylaxis in Pregnancy. Antiviral Therapy. 13(8). 1039–1046. 16 indexed citations
14.
Hentig, Nils von, Gaby Knecht, Amina Carlebach, et al.. (2008). The steady-state pharmacokinetics of atazanavir/ritonavir in HIV-1-infected adult outpatients is not affected by gender-related co-factors. Journal of Antimicrobial Chemotherapy. 62(3). 579–582. 26 indexed citations
15.
Stephan, Christoph, Amina Carlebach, Annette Haberl, et al.. (2007). Dose reduction effective in alleviating symptoms of saquinavir toxicity. International Journal of STD & AIDS. 18(2). 81–84. 3 indexed citations
16.
Hentig, Nils von, et al.. (2007). Tenofovir comedication does not impair the steady-state pharmacokinetics of ritonavir-boosted atazanavir in HIV-1-infected adults. European Journal of Clinical Pharmacology. 63(10). 935–940. 36 indexed citations
17.
Staszewski, Schlomo, Christoph Stephan, Annette Haberl, et al.. (2006). The LOPSAQ study: 48 week analysis of a boosted double protease inhibitor regimen containing lopinavir/ritonavir plus saquinavir without additional antiretroviral therapy. Journal of Antimicrobial Chemotherapy. 58(5). 1024–1030. 29 indexed citations
18.
Hentig, Nils von, Amina Carlebach, Peter Gute, et al.. (2006). A comparison of the steady‐state pharmacokinetics of nevirapine in men, nonpregnant women and women in late pregnancy. British Journal of Clinical Pharmacology. 62(5). 552–559. 34 indexed citations
19.
Haberl, Annette, Peter Fischer, D. Pongratz, & Jörn Peter Sieb. (2005). Chloroquin-induzierte Myopathie. Zeitschrift für Rheumatologie. 64(4). 274–276. 1 indexed citations
20.
Adamietz, Irenä us A., Stephan Mose, Annette Haberl, et al.. (1994). Effect of self‐adhesive, silicone‐coated polyamide net dressing on irradiated human skin. Radiation Oncology Investigations. 2(6). 277–282. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026